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Congenital pulmonary airway
malformation (CPAM), previously
known as congenital adenomatoid
malformation (CCAM), is a rare
developmental anomaly in the
respiratory tract.
Identified in 1949 by Ch’in and Tang,
where they reviewed ten previously
reported cases of a “solid-appearing
mass consisting of an adenomatoid
or gland-like proliferation of
terminal respiratory structures
occurred in stillborn or premature
neonates with hydrops”(Rosado-DeChristenson & Stocker, 1991).
CPAM “represents 25% of congenital
lung malformations and 95% of
congenital lung lesions” (Fulghum &
Vasquez 2002).
In 1977 The Stocker Classification
system was created to identify the
different types of CPAM. Currently
the Stocker Classification system has
identified Types 0-4. Although rare,
CPAM is the most common
congenital lung lesion detected
prenatally.
Due to the effectiveness of prenatal
ultrasound screening, CPAM is commonly
diagnosed between 18-21 week gestation
(Katarzyna & Impey, 2015).
There are CPAM lesions that are not
identified during routine ultrasounds
and present later in life.
According to Katarzyna & Impey, “this
lesion occurs more often in males and is
primarily unilateral, but may occur
bilaterally.
Most CPAMS are manageable with early
diagnosis and intervention. CPAM Stoker
type 1 is the most common subtype,
represents 60-70% of lesions, and this I
why I have chosen to focus on this lesion.

Pathophysiological Processes
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Signs and Symptoms

During pregnancy lung development occurs over the course of 5 distinct
stages.
Embryonic stage, during weeks 4-7, initiates the development of lung
buds, branching and vascular development.
Pseudoglandular stage, during weeks 7-17, consists of the growth and
branching of the tracheobronchial tree.
Terminal branching occurs in the Cannicular stage, weeks 16-23.
Gas exchange is initiated during the Saccular stage during weeks 24-38.
Lastly, in the Aveolar stage terminal alveoli form, and this stage starts at
38 weeks and continues until age 2 (McBride, 2016).
CPAM develops during the early stages of lung development. Although,
the exact pathogenesis is unknown, it is suspected that “abnormal events
during organogenesis result in the formation” of lung lesions (McBride,
2016).
Gajewska-Knapik & Limpey 2015, state “there is a failure of maturation
of bronchiolar structures during pseudoglandular stage of lung
development. It results in overgrowth of the terminal bronchioles
without corresponding alveoli. CPAM have a normal blood supply from
the pulmonary arteries and communicate with the tracheobronchial tree
(Gajewksa-Knapik & Limpey, 2015).
Large fetal CPAM specimens that were resected displayed “increased cell
proliferation and decreased apoptosis compared with gestational agematched normal fetal lung tissue (Azizkhan & Crombleholme 2008).
Three genes have been implicated in the pathogenesis of CPAM. The
HOXB5, Fgf7 and PDGF-B play a critical role in “branching
morphogenesis, induction of growth factors, mesenchymal
proliferations, and mesenchymal-epithelial interactions”(Azizkhan &
Crombleholme 2008).

•

•

 Antenatal presentation
CPAM may manifest in a mother who displays polyhydramnios. It is “been
proposed that impaired fetal swallowing due to mass effect on the esophagus,
increased fluid production or decreased fluid absorption by the lesion, and
secretion of antidiuretic hormone (Rosado-de-Christenson & Stocker, 1991).
Nonimmune Hydrops is seen in CPAM and is thought to be due to impaired
cardiac contractility and impaired venous return to the heart due to compression
of the heart and inferior vena cava by the lesion (Rosado-de-Christenson &
Stoker, 1991).
 Postnatal presentation
The majority of newborns present with respiratory distress immediately
following delivery. The infant may display grunting, tachypnea, retractions, and
cyanosis. Upon auscultation, the healthcare provider may notice diminished
breath sounds and distant or shifted heart sounds (Rosado-de-Christenson &
Stoker, 1991).

Type 1 CPAM
•
composed of single or multiple large cysts, ranging from three to ten
centimeters surrounded by smaller cysts
•
Predominant cystic type. They are Confined to one lobe, and are filled
with air or fluid.
•
Some lesions to communicate with bronchi associated anomalies are rare
in this subtype.
•
Present during the first week to month of life
•
Larger cysts are lined with pseudostratified columnar epithelium
•
Smaller cysts are lined with cuboidal to cells, typically seen in clusters

CT scan of Type 1 CPAM in right lobe
Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID:
8277
http://radiopaedia.org/articles/congenital-pulmonary-airwaymalformation

Clinical Implications
CPAM are increasingly being
diagnosed during pregnancy. Accurate
diagnosis of lung lesions is important
as the treatment of lesions may differ
depending on the type. Although most
lung lesions are detected during
antepartum, some are not, therefore it
is imperative that health care
providers be informed of the
pathogenesis and presentation of
patients with CPAM. Infants
presenting with respiratory distress
will require healthcare providers who
are trained in stabilization and
resuscitation of the newborn.
Mechanical ventilation may be
required if respiratory distress is
severe. Health care providers must be
aware of the risk of pneumothorax,
pnuemopericadiam, and
pneumomediastinum in patients
receiving mechanical ventilation.
Frequent assessments of respiratory
status is required as well as serial xrays to monitor the need and level of
support (Fulghum & Vasquez, 2002).

Conclusion
Infant displacing subcostal retractions during respiratory distress. Retrieved July 25th,
2016 from newborns.standford.edu. Photographed by Dr. Janelle Abey

•

Figure 1 Stages of lung development (Hameed, et al 2013)

 Early Infancy/Childhood/Adulthood
Infants present with respiratory distress, vomiting, failure to thrive, and
recurrent pneumonia. Children and adults typically present with recurrent
infection localized to the involved lobe of the lung.(Rosado-de-Christenson &
Stoker, 1991).

CPAM is a rare congenital anomaly that
typically presents in the neonatal period
during lung development. Early
detection of CPAM usually occurs during
routine ultrasounds. Infants with CPAM
may present with respiratory distress at
birth and the need for prompt
respiratory support and immediate
surgical intervention. The prognosis of
infants who present with CPAM is
dependent upon the size of the lesion,
the development of healthy lung tissue,
and the presence of other anomalies.
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